TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.80
-0.01 (-0.13%)
Apr 29, 2026, 2:00 PM CST
-1.89%
Market Cap 635.37M
Revenue (ttm) n/a
Net Income (ttm) -24.34M
Shares Out 80.12M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 53,138
Average Volume 359,501
Open 7.81
Previous Close 7.81
Day's Range 7.56 - 7.93
52-Week Range 7.00 - 10.60
Beta -1.26
RSI 48.20
Earnings Date May 5, 2026

About TaiwanJ Pharmaceuticals

TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 13
Stock Exchange Taipei Exchange
Ticker Symbol 6549
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.